MENU
+Compare
BMXMF
Stock ticker: OTC
AS OF
Nov 5 closing price
Price
$128.98
Change
+$3.79 (+3.03%)
Capitalization
14.78B

BMXMF Biomerieux 69 Marcy L'Etoile Forecast, Technical & Fundamental Analysis

BioMérieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination... Show more

BMXMF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for BMXMF with price predictions
Nov 12, 2025

BMXMF's RSI Indicator ascends from oversold territory

The RSI Indicator for BMXMF moved out of oversold territory on November 03, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 40 similar instances when the indicator left oversold territory. In of the 40 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for BMXMF just turned positive on October 23, 2025. Looking at past instances where BMXMF's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

BMXMF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Momentum Indicator moved below the 0 level on November 12, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BMXMF as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Aroon Indicator for BMXMF entered a downward trend on November 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.341) is normal, around the industry mean (12.372). P/E Ratio (35.208) is within average values for comparable stocks, (132.213). Projected Growth (PEG Ratio) (1.857) is also within normal values, averaging (1.928). Dividend Yield (0.008) settles around the average of (0.017) among similar stocks. P/S Ratio (3.212) is also within normal values, averaging (9.791).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BMXMF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMXMF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
BMXMF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published Dividends

BMXMF paid dividends on June 08, 2021

Biomerieux 69 Marcy L'Etoile BMXMF Stock Dividends
А dividend of $0.62 per share was paid with a record date of June 08, 2021, and an ex-dividend date of June 04, 2021. Read more...
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
Marcy l’Etoile
Phone
+33 478872000
Employees
13982
Web
http://www.biomerieux.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SAMM30.110.21
+0.70%
Strategas Macro Momentum ETF
GUNR44.850.17
+0.38%
FlexShares Mstar Glbl Upstrm Nat Res ETF
TRSY30.100.01
+0.02%
Xtrackers US 0-1 Year Treasury ETF
GXUS55.11N/A
N/A
Goldman Sachs MarketBeta(R) Ttl IntEqETF
WCBR31.48-0.59
-1.84%
WisdomTree Cybersecurity ETF

BMXMF and Stocks

Correlation & Price change

A.I.dvisor tells us that BMXMF and SOAGY have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BMXMF and SOAGY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMXMF
1D Price
Change %
BMXMF100%
N/A
SOAGY - BMXMF
26%
Poorly correlated
-0.07%
FONR - BMXMF
24%
Poorly correlated
+0.34%
SRTOY - BMXMF
23%
Poorly correlated
N/A
SNN - BMXMF
22%
Poorly correlated
+0.57%
BIO - BMXMF
21%
Poorly correlated
+4.45%
More